Induction of estradiol metabolism by dietary indole-3-carbinol in humans

J J Michnovicz1, H L Bradlow

  • 1Rockefeller University, New York, NY.

Insights

Dietary indoles, like indole-3-carbinol found in cruciferous vegetables, can alter estradiol metabolism. This suggests a potential new strategy for preventing estrogen-dependent diseases and cancers.

Area of Science:

  • Biochemistry
  • Oncology
  • Nutritional Science

Background:

  • Dietary indoles from cruciferous vegetables are known to induce cytochrome P450 enzymes.
  • These enzymes play a crucial role in metabolizing estradiol, a hormone linked to breast cancer risk.
  • Indoles show potential for preventing tumors in animal models, suggesting a similar effect on estrogen-responsive cancers.

Purpose of the Study:

  • To investigate the effect of dietary indoles on hepatic estradiol 2-hydroxylation.
  • To determine if indole-3-carbinol can alter estradiol metabolism in humans.
  • To explore the potential of indole-3-carbinol as a chemopreventive agent for estrogen-dependent diseases.

Main Methods:

  • Several indoles were tested in female Sprague-Dawley rats to assess their ability to induce hepatic estradiol 2-hydroxylation.
  • The most potent indole, indole-3-carbinol, was administered to human participants at a dosage of 500 mg daily for one week.
  • Estradiol 2-hydroxylation levels were measured before and after indole-3-carbinol administration in humans.

Main Results:

  • Indole-3-carbinol was identified as the most potent inducer of hepatic estradiol 2-hydroxylation in rats.
  • In human participants, indole-3-carbinol significantly increased estradiol 2-hydroxylation from 29.3% +/- 2.1% to 45.6% +/- 2.1% (P < .001).
  • These findings demonstrate a strong influence of indole-3-carbinol on human estradiol metabolism.

Conclusions:

  • Indole-3-carbinol significantly enhances estradiol 2-hydroxylation in humans.
  • This modulation of estradiol metabolism suggests indole-3-carbinol may offer a novel chemopreventive approach.
  • Further research into indole-3-carbinol could lead to new strategies for managing estrogen-dependent diseases and reducing cancer risk.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...